Mankind Pharma
MANKIND · Pharma > Pharmaceuticals & Drugs Listing date: May 9, 2023

Stock Price vs Company Growth
1d
0.7%
1w
2.3%
1m
5.5%
3m
2.8%
6m
3.0%
1y
10.6%
all
15.6%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 2,306 0.7%
2,301
2,640
Company Overview

Sales
14,738 Cr
Growth: 14.2%
Profit after Tax
2,043 Cr
Growth: 6.8%
Large Cap
95,242 Cr
P/E: 46.7x
Industry P/E: 34.2x
Fundamentals

Sales (Cr) ₹ 14,738
Growth 14.2%
EBITDA 26.0%
P/S 6.5x
Dividend 0.0%
P/E 46.7x
Book Value ₹ 408
PEG Ratio 3.3x
ROE 12.7%
P/B 5.7x
Shareholding Pattern

Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed

The company is India’s one of the leading pharmaceutical company with a diversified portfolio - from pharma and super specialty to consumer healthcare backed by strong in-house R&D capabilities with an established and deeply penetrated presence across India. The company is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products.
Investors (1)
Followers (2)